Multidrug-resistant Pseudomonas aeruginosa infection
Definition:
References:
-
[1]. Elizabeth B Hirsch, et al. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res. 2010 Aug;10(4):441-51. [Content Brief]
[2]. I Nakamura, et al. New options of antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):83-87. [Content Brief]
[3]. John Quale, et al. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2006 May;50(5):1633-41. [Content Brief]
[4]. Julie Jeukens, et al. Complete Genome Sequence of Persistent Cystic Fibrosis Isolate Pseudomonas aeruginosa Strain RP73. Genome Announc. 2013 Aug 1;1(4):e00568-13. [Content Brief]
[5]. N Mesaros, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect. 2007 Jun;13(6):560-78. [Content Brief]
[6]. Paul H Roy, et al. Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLoS One. 2010 Jan 22;5(1):e8842. [Content Brief]
[7]. Tohru Miyoshi-Akiyama, et al. Complete genome sequence of highly multidrug-resistant Pseudomonas aeruginosa NCGM2.S1, a representative strain of a cluster endemic to Japan. J Bacteriol. 2011 Dec;193(24):7010. [Content Brief]
[8]. Yuji Morita, et al. Responses of Pseudomonas aeruginosa to antimicrobials. Front Microbiol. 2014 Jan 8;4:422. [Content Brief]